Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 76 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immune Design Corp. | 6,642,942 | reported | 27 Oct 2017 | tx 12+6,271,076−3,191,060 |
| CONSTELLATION PHARMACEUTICALS INC | 6,051,376 | reported | 20 Mar 2020 | tx 2+41,674 |
| TULARIK INC | 350,000 | reported | 21 Mar 2003 | tx 1+350,000 |
| Tenaya Therapeutics, Inc. | 107,400 | reported | 29 May 2025 | tx 22+112,441,768−9,346,124 |
| NGM BIOPHARMACEUTICALS INC | 0 | reported | 05 Apr 2024 | tx 161+21,409,736−48,737,914 |
| RAPT Therapeutics, Inc. | 0 | reported | 04 Nov 2019 | tx 13+6,727,151−36,612,933 |
| Gritstone Oncology, Inc. | 0 | reported | 02 Oct 2018 | tx 3+3,102,934−3,102,934 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2025 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 107,400 | 0.00 USD | deriv |
| 05 Mar 2025 | PURCHASE | Tenaya Therapeutics, Inc. | 35,714,284 | 0.70 USD | |
| 05 Mar 2025 | PURCHASE | Tenaya Therapeutics, Inc. | 35,714,284 | — | deriv |
| 05 Mar 2025 | PURCHASE | Tenaya Therapeutics, Inc. | 17,857,142 | — | derivfirst after silence |
| 18 Oct 2024 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 34,000 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 100,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 100,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 1,298,908 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 1,298,908 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 2,265,758 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 968,990 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 858,035 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 11,103,333 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 90,442 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 2,650,177 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 949,862 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 190,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 134,180 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 1,000 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 78,407 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 24,222 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 19,619 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 24,000 | — | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 16,806 | — | deriv |
| 12 Feb 2024 | PURCHASE | Tenaya Therapeutics, Inc. | 2,222,222 | 4.50 USD |
4 purchases reported after at least 12 months of silence — most recent on 05 Mar 2025.